Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD
2.66 -0.63 (-19.15%)
Jan 24, 2022 4:00 PM EST - Market closed
Market Capn/a
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Outn/a
EPS (ttm)-4.77
PE Ration/a
Forward PE7.79
Dividendn/a
Ex-Dividend Daten/a
Volume4
Openn/a
Previous Close3.29
Day's Range2.58 - 3.30
52-Week Range2.58 - 11.29
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About REVB

Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal co...

IndustryBiotechnology
Founded2020
Employees2
Stock ExchangeNASDAQ
Ticker SymbolREVB
Full Company Profile

News

Revelation Biosciences Raises $7.76 Million in Equity Financing

SAN DIEGO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immu...

1 day ago - GlobeNewsWire

REPEAT -- Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS...

-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed-

1 week ago - GlobeNewsWire

Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Bio...

-The Definitive Proxy Statement Has Been Filed with The Securities and Exchange Commission-

1 month ago - GlobeNewsWire

Respiratory Viral Infections-Focused Revelation Biosciences Turns To SPAC Deal For NASDAQ Debut

Revelation Biosciences Inc is joining Petra Acquisition Inc (NASDAQ: PAIC) to create a NASDAQ-listed company with an enterprise value of $128 million.  The merger is expected to close in Q4 2021, and th...

4 months ago - Benzinga

PETRA ACQUISITION, INC. ANNOUNCES SECURITIES TO COMMENCE SEPARATE TRADING

New York, NY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Petra Acquisition, Inc. (NASDAQ: PAICU) (the “Company”) announced today that separate trading of its shares of common stock and warrants underlying the Co...

1 year ago - GlobeNewsWire

Petra Acquisition Inc. Announces Closing of $70 Million Initial Public Offering

New York, NY, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Petra Acquisition, Inc. (Nasdaq: PAICU) (the “Company”) is a blank check company organized for the purpose of effecting a merger, share exchange, asset ac...

1 year ago - GlobeNewsWire

Sandy Spring Bancorp Completes Acquisition of Revere Bank

Bank Deepens Presence in the Region and Welcomes New Executives and Directors Bank Deepens Presence in the Region and Welcomes New Executives and Directors

Other symbols:SASR
1 year ago - GlobeNewsWire